• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Chiba University - Developmental Therapeutics Review - Q4 2010 Product Image

Chiba University - Developmental Therapeutics Review - Q4 2010

  • ID: 1464347
  • December 2010
  • 32 pages
  • Global Markets Direct

Chiba University – Developmental Therapeutics Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Chiba University - Developmental Therapeutics Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Chiba University - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Chiba University human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment READ MORE >



List of Tables
List of Figures
Chiba University Snapshot
Chiba University Overview
Key Information
Key Facts
Chiba University – Research and Development Overview
Key Therapeutic Areas
Chiba University – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Chiba University – Pipeline Products Glance
Chiba University – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Chiba University Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Chiba University – Drug Profiles
Lactobacillus
Product Description
Mechanism of Action
R&D Progress
Pioglitazone
Product Description
Mechanism of Action
R&D Progress
Alpha-GalactosylCeramide-Pulsed Dendritic Cells + Natural Killer T Cells
Product Description
Mechanism of Action
R&D Progress
Cisplatin + S-1
Product Description
Mechanism of Action
R&D Progress
CPT-11 + CDDP
Product Description
Mechanism of Action
R&D Progress
Docetaxel + Nedaplatin
Product Description
Mechanism of Action
R&D Progress
Erlotinib
Product Description
Mechanism of Action
R&D Progress
Ezetimibe
Product Description
Mechanism of Action
R&D Progress
Granulocyte Colony-Stimulating Factor
Product Description
Mechanism of Action
R&D Progress
Pitavastatin Calcium
Product Description
Mechanism of Action
R&D Progress
Chiba University – Pipeline Analysis
Chiba University – Pipeline Products by Therapeutic Class
Chiba University Pipeline Products By Target
Chiba University – Pipeline Products by Route of Administration
Chiba University – Pipeline Products by Molecule Type
Chiba University - Dormant Projects
Chiba University – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS